Cabergoline and aortic valve sclerosis 
Cabergoline and aortic valve sclerosis Patient Reports February 12, 2012
Cabergoline Side Effects Report #5073518-9
Cabergoline side effect was reported by a Physician from GERMANY on July 21, 2006. Male patient, 70 years of age, was diagnosed with restless legs syndrome and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, aortic valve sclerosis. Cabergoline dosage: 1 MG (DAILY),ORAL 7 YEARS AGO. Patient recovered.
Cabergoline Side Effects Report #5087115-2
Cabergoline side effect was reported by a Physician from GERMANY on Aug 10, 2006. Female patient, 69 years of age, was diagnosed with restless legs syndrome and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, aortic valve sclerosis, biliary cirrhosis primary. Cabergoline dosage: 1 MG (DAILY) ORAL. During the same period patient was treated with URSOFALK. Patient recovered.
Cabergoline Side Effects Report #5120033-X
Cabergoline side effect was reported by a Physician from GERMANY on Sept 18, 2006. Female patient, 69 years of age, was diagnosed with restless legs syndrome and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic arteriosclerosis, aortic valve incompetence, aortic valve sclerosis. Cabergoline dosage: 1 MG (1 D), ORAL. During the same period patient was treated with URSO FALK, ACETYLSALICYLIC ACID SRT. Patient recovered.
Cabergoline Side Effects Report #4699662-3
Cabergoline side effect was reported by a Physician from on June 14, 2005. Female patient, 65 years of age, weighting 149.9 lb, was diagnosed with restless legs syndrome and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve calcification, aortic valve incompetence, aortic valve sclerosis, coronary artery surgery, hypertension. Cabergoline dosage: 2 MG (2 MG, DAILY) ORAL. During the same period patient was treated with ACETYLSALICYLIC ACID SRT, ISOMONIT, LOVASTATIN, CARVEDILOL. Patient was hospitalized. Patient recovered.
Cabergoline Side Effects Report #5385694-9
Cabergoline side effect was reported by a Physician from GERMANY on July 02, 2007. Female patient, weighting 174.2 lb, was diagnosed with restless legs syndrome and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, aortic valve sclerosis. Cabergoline dosage: DAILY DOSE:1MG. Patient recovered.
Cabergoline Side Effects Report #5502491-1
Cabergoline side effect was reported by a Physician from GERMANY on Oct 18, 2007. Female patient, weighting 132.3 lb, was diagnosed with parkinsonism and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, aortic valve sclerosis, left ventricular dysfunction, mitral valve incompetence, mitral valve sclerosis, tricuspid valve incompetence. Cabergoline dosage: DAILY DOSE:10MG. Patient recovered.
Cabergoline Side Effects Report #4966139-7
Cabergoline side effect was reported by a Consumer or non-health professional from GERMANY on Mar 27, 2006. Female patient, 81 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic arteriosclerosis, aortic valve incompetence, aortic valve sclerosis, dilatation atrial, left ventricular failure, mitral valve disease, mitral valve incompetence, tricuspid valve incompetence. Cabergoline dosage: 4 MG, ORAL. During the same period patient was treated with AMANTADINE, NACOM. Patient recovered.Cabergoline Side Effects Report #5094391-9
Cabergoline side effect was reported by a Physician from GERMANY on Aug 16, 2006. Female patient, 75 years of age, weighting 176.4 lb, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, aortic valve sclerosis, hypertensive heart disease, mitral valve incompetence. Cabergoline dosage: 2 MG (DAILY), ORAL. During the same period patient was treated with MADOPAR, BISOPROLOL, HYDROCHLOROTHIAZIDE. Patient recovered.Cabergoline Side Effects Report #5094396-8
Cabergoline side effect was reported by a Physician from DENMARK on Aug 16, 2006. Male patient, 73 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve sclerosis, dyspnoea, mitral valve incompetence, mitral valve sclerosis, pleural fibrosis. Cabergoline dosage: 6 MG (DAILY), ORAL. During the same period patient was treated with CORODIL, COMTESS, SINEMET. Patient recovered.Cabergoline Side Effects Report #4688270-6
Cabergoline side effect was reported by a Physician from on May 27, 2005. Male patient, 73 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve sclerosis, cardiac valve disease, dyspnoea, fibrosis, mitral valve incompetence, mitral valve sclerosis, pleural fibrosis. Cabergoline dosage: 6 MG (DAILY), ORAL. During the same period patient was treated with CORODIL, COMTESS, SINEMET. Patient recovered.Cabergoline Side Effects Report #4996295-6
Cabergoline side effect was reported by a Physician from SPAIN on Apr 27, 2006. Male patient, 73 years of age, weighting 213.8 lb, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic elongation, aortic valve incompetence, aortic valve sclerosis, atrial fibrillation , cardiac failure, cardiac murmur, cardiomegaly. Cabergoline dosage: 3 MG (DAILY), ORAL. During the same period patient was treated with SINEMET. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #4781130-1
Cabergoline side effect was reported by a Physician from SPAIN on Sept 14, 2005. Male patient, 72 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, aortic valve sclerosis, cardiac failure. Cabergoline dosage: 2 MG (DAILY), ORAL. During the same period patient was treated with SINEMET. Patient recovered.Cabergoline Side Effects Report #4874914-2
Cabergoline side effect was reported by a Physician from SPAIN on Dec 28, 2005. Male patient, 72 years of age, weighting 213.8 lb, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic disorder, aortic valve incompetence, aortic valve sclerosis, atrial fibrillation , cardiac failure, cardiac murmur, cardiomegaly. Cabergoline dosage: 3 MG (DAILY), ORAL. During the same period patient was treated with SINEMET. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #4931079-6
Cabergoline side effect was reported by a Physician from GERMANY on Feb 13, 2006. Male patient, 71 years of age, weighting 163.1 lb, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, aortic valve sclerosis, dyspnoea exertional, mitral valve incompetence. Cabergoline dosage: 6 MG (2 MG, 2 IN 1 D), ORAL. During the same period patient was treated with STALEVO, AMANTADINE, ACETYLSALICYLIC ACID SRT. Patient recovered.Cabergoline Side Effects Report #4960888-2
Cabergoline side effect was reported by a Physician from GERMANY on Mar 14, 2006. Male patient, 71 years of age, weighting 163.1 lb, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic dilatation, aortic valve incompetence, aortic valve sclerosis, dyspnoea exertional, mitral valve incompetence. Cabergoline dosage: 6 MG (2 MG, 2 IN 1 D), ORAL. During the same period patient was treated with STALEVO, AMANTADINE, ACETYLSALICYLIC ACID SRT. Patient recovered.Cabergoline Side Effects Report #4700637-6
Cabergoline side effect was reported by a Physician from on June 14, 2005. Female patient, 68 years of age, weighting 143.3 lb, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve sclerosis, mitral valve sclerosis. Cabergoline dosage: MAXIMAL 2MG (DAILY); ORAL. During the same period patient was treated with AMANTADINE, MADOPAR. Patient recovered.Cabergoline Side Effects Report #4990045-5
Cabergoline side effect was reported by a Physician from GERMANY on Apr 21, 2006. Male patient, 57 years of age, weighting 176.4 lb, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve sclerosis. Cabergoline dosage: 4 MG, ORAL. During the same period patient was treated with NACOM. Patient recovered.Cabergoline Side Effects Report #5018360-X
Cabergoline side effect was reported by a Physician from GERMANY on May 18, 2006. Male patient, 57 years of age, weighting 176.4 lb, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve sclerosis. Cabergoline dosage: 4 MG, ORAL. During the same period patient was treated with NACOM. Patient recovered.Cabergoline Side Effects Report #5165034-0
Cabergoline side effect was reported by a Physician from GERMANY on Nov 14, 2006. Male patient, 45 years of age, weighting 176.4 lb, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, aortic valve sclerosis, pulmonary hypertension , tricuspid valve incompetence, ventricular hypertrophy. Cabergoline dosage: 6 MG (1 D); ORAL. During the same period patient was treated with PERGOLIDE MESYLATE, AMANTADINE, SELEGILINE, MADOPAR. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #5228273-6
Cabergoline side effect was reported by a Physician from AUSTRIA on Jan 19, 2007. Female patient was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve sclerosis, cardiac valve disease, heart valve insufficiency, mitral valve disease. Cabergoline dosage: unknown. Patient recovered.Cabergoline Side Effects Report #5228299-2
Cabergoline side effect was reported by a Physician from AUSTRIA on Jan 19, 2007. Female patient was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve sclerosis, cardiac valve disease, heart valve insufficiency, mitral valve disease. Cabergoline dosage: unknown. Patient recovered.Cabergoline Side Effects Report #5228332-8
Cabergoline side effect was reported by a Physician from AUSTRIA on Jan 19, 2007. Female patient was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve sclerosis, cardiac valve disease, heart valve insufficiency, mitral valve disease. Cabergoline dosage: unknown. Patient recovered.Cabergoline Side Effects Report #5228339-0
Cabergoline side effect was reported by a Physician from AUSTRIA on Jan 19, 2007. Female patient was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve sclerosis, cardiac valve disease, heart valve insufficiency, mitral valve disease. Cabergoline dosage: unknown. Patient recovered.Cabergoline Side Effects Report #5228342-0
Cabergoline side effect was reported by a Physician from AUSTRIA on Jan 19, 2007. Female patient was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve sclerosis, cardiac valve disease, heart valve insufficiency, mitral valve disease. Cabergoline dosage: unknown. Patient recovered.Cabergoline Side Effects Report #5087061-4
Cabergoline side effect was reported by a Physician from GERMANY on Aug 08, 2006. Male patient was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: antinuclear antibody increased, aortic valve sclerosis, mitral valve sclerosis, oedema peripheral, tricuspid valve sclerosis. Cabergoline dosage: unknown. Patient recovered.Cabergoline Side Effects Report #5106231-X
Cabergoline side effect was reported by a Physician from GERMANY on Aug 30, 2005. Male patient was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: antinuclear antibody increased, aortic valve sclerosis, incorrect dose administered, mitral valve sclerosis, oedema peripheral, tricuspid valve sclerosis. Cabergoline dosage: unknown. Patient recovered.Cabergoline Side Effects Report #5133242-0
Cabergoline side effect was reported by a Physician from GERMANY on Oct 05, 2006. Male patient was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: antinuclear antibody increased, aortic valve incompetence, aortic valve sclerosis, dilatation ventricular, mitral valve incompetence, mitral valve prolapse, mitral valve sclerosis, oedema peripheral, treatment noncompliance. Cabergoline dosage: unknown. Patient recovered.Cabergoline Side Effects Report #4710538-5
Cabergoline side effect was reported by a Physician from GERMANY on June 27, 2005. Female patient, weighting 132.3 lb, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, aortic valve sclerosis, cardiac output decreased, coronary artery atherosclerosis, dyspnoea, mitral valve disease, mitral valve incompetence, mitral valve sclerosis, pleural effusion. Cabergoline dosage: DAILY, ORAL ; 6 MG (DAILY) ORAL. During the same period patient was treated with SELEGILINE, TEBONIN, NEUROPLANT, BISOPROLOL FUMARATE, GINGIUM, FUROSEMIDE, HEPARIN. Patient was hospitalized and became disabled. Patient recovered.Cabergoline Side Effects Report #4765276-X
Cabergoline side effect was reported by a Physician from GERMANY on Aug 26, 2005. Female patient, weighting 132.3 lb, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, aortic valve sclerosis, coronary artery disease , mitral valve incompetence, mitral valve sclerosis, pleural effusion, pneumonia , pulmonary congestion, tricuspid valve incompetence. Cabergoline dosage: unknown. During the same period patient was treated with SELEGELINE HYDROCHLORIDE, TEBONIN, NEUROPLANT, BISOPROLOL FUMARATE, GINGIUM, FUROSEMIDE, HEPARIN. Patient was hospitalized and became disabled. Patient recovered.